The released batch was manufactured at Everest's Jiashan manufacturing site using the Company's proprietary mRNA platform, in compliance with global GMP standards. EVM14 is an off-the-shelf ...

Quanyin Hu, a professor in the UW-Madison School of Pharmacy, said the approach could theoretically be applied to any cancer ...

A study in Chemistry A European Journal reveals that reduced MUC1 antigen density on gold nanoparticles still elicits potent ...

While research in mice has shown encouraging results, the next phases of human trials will need to confirm safety and ...

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing ...

We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...

US researchers have found that developing personalised vaccines can play a key role in keeping aggressive tumours from ...

Trained immunity is a form of innate immune cell memory that is being developed as a novel immunotherapeutic approach for cancer treatment.

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has dosed its first patient in the ...

For decades, vaccines have been seen as tools to prevent disease, protecting us from measles, flu, and even certain types of ...

A vaccine that could help fight one of the deadliest forms of cancer is in the works - and could one day become a reality.

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...